Evvy
Company

Last deal

$14M

Amount

Series A

Stage

27.09.2023

Date

3

all rounds

$31M

Total amount

General

About Company
Evvy is a company that aims to revolutionize the understanding and treatment of the female body, starting with the vaginal microbiome.

Industry

Sector :

Subsector :

founded date

01.01.2020

Number of employees

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

Evvy has developed the first-ever at-home vaginal microbiome test that uses metagenomic sequencing to identify imbalances in the vaginal microbiome, which can cause bacterial vaginosis, yeast infections, and recurrent UTIs. The test provides personalized reports and recommendations for improving vaginal health based on the unique microbiome of each individual. Evvy also offers a free consultation with a certified health coach to discuss the results and prepare patients to talk to their doctor if needed. The company's larger platform combines testing, clinical care, and coaching to provide comprehensive care for women and people with vaginas. By leveraging overlooked female biomarkers, Evvy is closing the gender health gap and building real-world datasets to transform our understanding of complex female health conditions.
Contacts

Phone number

Social url